Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 12/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CSF1R | P07333 | 1/20 | 0.37 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.37 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5661824 | 0.92 | KCNA5 (0.41) | KCNA5ALDH1A1GAATAAR1NPC1 | |
| SCHEMBL2889224 | 0.90 | KCNA5 (0.43) | KCNA5ALDH1A1NPC1RAB9AKCNE1 | |
| SCHEMBL2883788 | 0.86 | KCNA5 (0.43) | KCNA5ALDH1A1GAATAAR1NPC1 | |
| SCHEMBL2889515 | 0.85 | KCNA5 (0.43) | KCNA5ALDH1A1GAATAAR1NPC1 | |
| SCHEMBL2891148 | 0.83 | SMN1; SMN2 (0.48) | KCNA5ALDH1A1TAAR1NPC1RAB9A | |
| SCHEMBL2891249 | 0.83 | KCNA3 (0.40) | KCNA5ALDH1A1GAATAAR1NPC1 | |
| SCHEMBL2891262 | 0.83 | KCNA5 (0.43) | KCNA5ALDH1A1GAATAAR1NPC1 | |
| SCHEMBL2889346 | 0.82 | KCNA5 (0.44) | KCNA5NPC1RAB9AKCNE1KCNQ1 | |
| SCHEMBL2891657 | 0.81 | KCNA5 (0.44) | KCNA5NPC1RAB9AKCNE1KCNQ1 | |
| SCHEMBL2887624 | 0.79 | ABCB1 (0.46) | KCNA5ALDH1A1GAAALOX15KCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7781483-B2 | Benzopyran compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-08-24 | — | — | US | disclosed |
| US-20070299130-A1 | Benzopyran Compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070299130-A1 | Benzopyran Compound | NR0B1, CYP2B6, RYR2 | KCNA5 69/4885ALDH1A1 2971/4885GAA 4316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.